Funding for this research was provided by:
Arthritis Australia (2018 Arthritis Australia Grant)
Stephen Hall (N/A)
Text and Data Mining valid from 2018-03-27
Received: 29 November 2017
Accepted: 28 February 2018
First Online: 27 March 2018
Ethics approval and consent to participate
: Liverpool Hospital, BJC Health (Parramatta and Chatswood), Royal North Shore Hospital (South Western Sydney Local Health District Research and Ethics Office, Locked Bag 7103, Liverpool BC NSW 1871, Australia, approval number HE 16/373 LNR, approved 2 March 2017), Canberra Hospital and Canberra Rheumatology (Australian Capital Territory Health Human Research Ethics Committee, ACT Government Health Directorate Research Office, Building 10 Level 6, Canberra Hospital, Yamba Drive, Garran ACT 2605, Australia, approval number ETHLR.15.137, approved 11 August 2015) have provided an ethical review and approval for the phase 2 and 3 studies. Ethics approval will be sought for the remainder of the OMERACT study. The primary investigator or co-ordinating investigator at each study site will obtain informed consent from all participants in the study (available on request).
: Not applicable.
: PT, LM, MDW, DB and JAS are members of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. JAS has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta/Horizon and Allergan Pharmaceuticals, WebMD, UBM LLC and the American College of Rheumatology (ACR). JAS serves as the principal investigator for an investigator-initiated study funded by Horizon Pharmaceuticals through a grant to DINORA, Inc, a 501(c)(3) entity. JAS is a member of the ACR’s Annual Meeting Planning Committee; chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the director of the University of Alabama at Birmingham (UAB) Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. RC is a member of the Technical Advisory Group for the OMERACT Domain & Instrument Selection Process, which might be perceived as an intellectual conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.